US FDA’s Shuren: Device Center Will Roll Out New Strategic Priorities In 2022

 
• By Shawn M. Schmitt
  
Priorities word written with a typewriter.
The FDA's device center has extended the time frame for meeting its 2018 list of three strategic priorities through the end of 2021

More from Regulation

More from Policy & Regulation